These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26416303)

  • 21. Pharmacokinetics of low doses of methotrexate in patients with psoriasis over the early period of treatment.
    Chládek J; Martínková J; Simková M; Vanecková J; Koudelková V; Nozicková M
    Eur J Clin Pharmacol; 1998 Feb; 53(6):437-44. PubMed ID: 9551702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
    Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
    J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis.
    Løvendorf MB; Zibert JR; Gyldenløve M; Røpke MA; Skov L
    J Dermatol Sci; 2014 Aug; 75(2):133-9. PubMed ID: 24909097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy of methotrexate plus NBUVB phototherapy is more effective than methotrexate monotherapy in the treatment of chronic plaque psoriasis.
    Soliman A; Nofal E; Nofal A; El Desouky F; Asal M
    J Dermatolog Treat; 2015; 26(6):528-34. PubMed ID: 25909368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment.
    Yazici AC; Tursen U; Apa DD; Ikizoglu G; Api H; Baz K; Tasdelen B
    Arch Dermatol Res; 2005 Dec; 297(6):249-55. PubMed ID: 16215763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein.
    Moncrieffe H; Ursu S; Holzinger D; Patrick F; Kassoumeri L; Wade A; Roth J; Wedderburn LR
    Rheumatology (Oxford); 2013 Aug; 52(8):1467-76. PubMed ID: 23620557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.
    Chládek J; Grim J; Martínková J; Simková M; Vanìèková J; Koudelková V; Noièková M
    Br J Clin Pharmacol; 2002 Aug; 54(2):147-56. PubMed ID: 12207634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
    Dalaker M; Bonesrønning JH
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):277-82. PubMed ID: 19207642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
    Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
    Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.
    Boehncke S; Salgo R; Garbaraviciene J; Beschmann H; Hardt K; Diehl S; Fichtlscherer S; Thaçi D; Boehncke WH
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1187-93. PubMed ID: 21241371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin.
    Quist SR; Quist J; Birkenmaier J; Stauch T; Gollnick HP
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous methotrexate versus oral form for the treatment and prophylaxis of chronic plaque psoriasis.
    Attwa EM; Elkot RA; Abdelshafey AS; Hafez AR
    Dermatol Ther; 2019 Sep; 32(5):e13051. PubMed ID: 31381231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of concomitant use of PUVA and methotrexate in disease clearance time in plaque type psoriasis.
    Shehzad T; Dar NR; Zakria M
    J Pak Med Assoc; 2004 Sep; 54(9):453-5. PubMed ID: 15518366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriatic patients with chronic viral hepatitis do not have an increased risk of liver cirrhosis despite long-term methotrexate use: Real-world data from a nationwide cohort study in Taiwan.
    Tang KT; Chen YM; Chang SN; Lin CH; Chen DY
    J Am Acad Dermatol; 2018 Oct; 79(4):652-658. PubMed ID: 29753054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
    Nyfors A; Poulsen H
    Acta Pathol Microbiol Scand A; 1976 May; 84(3):262-70. PubMed ID: 1274591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate regulates Th-1 response by suppressing caspase-1 and cytokines in psoriasis patients.
    Thirupathi A; Elango T; Subramanian S; Gnanaraj P
    Clin Chim Acta; 2016 Jan; 453():164-9. PubMed ID: 26707913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis.
    Revicki D; Willian MK; Saurat JH; Papp KA; Ortonne JP; Sexton C; Camez A
    Br J Dermatol; 2008 Mar; 158(3):549-57. PubMed ID: 18047521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the systemic use of methotrexate on the oxidative stress and paraoxonase enzyme in psoriasis patients.
    Kilic S; Emre S; Metin A; Isikoglu S; Erel O
    Arch Dermatol Res; 2013 Aug; 305(6):495-500. PubMed ID: 23660995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy of platelet rich plasma in combination with methotrexate in chronic plaque psoriatic patients.
    Chakravdhanula U; Anbarasu K; Verma VK; Beevi SS
    Dermatol Ther; 2016 Nov; 29(6):446-450. PubMed ID: 27418241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model.
    Nagle A; Goyal AK; Kesarla R; Murthy RR
    J Liposome Res; 2011 Jun; 21(2):134-40. PubMed ID: 20557280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.